Multiple inflammatory and signaling proteins

Multiple inflammatory and signaling proteins is a collective term used to describe a broad array of molecular entities that mediate the body's immune and inflammatory responses. This group encompasses various classes of proteins, including pro-inflammatory cytokines like Tumor Necrosis Factor (TNF) and Interleukin-1 (IL-1), chemokines that direct cell migration, and intracellular signaling enzymes such as Janus kinases (JAKs) (Source: PubMed, PMC4711683). These proteins are essential for normal host defense and tissue repair; however, their chronic overactivation is a primary driver of autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, as well as chronic inflammatory conditions like asthma (Source: StatPearls, Inflammation). Because many diseases involve multiple redundant pathways, therapeutic strategies often employ drugs that interact with several of these proteins simultaneously. For example, corticosteroids like dexamethasone act broadly to suppress the transcription of numerous inflammatory genes, while multi-kinase inhibitors block several signaling nodes at once (Source: NIH, Drug Record). While this multi-target approach can be highly effective in controlling severe inflammation, it frequently results in significant safety challenges, including systemic immunosuppression and an increased risk of serious infections.

Other names

Inflammatory mediatorsPro-inflammatory signaling moleculesCytokines and signaling cascades

Broad-spectrum modulation of inflammatory gene expression, inhibition of multiple protein kinases, and suppression of cytokine production and signaling cascades.